Atlanta Braves designated hitter Jurickson Profar is reportedly facing a substantial 162-game suspension following a second positive test for performance-enhancing drugs within a year, a development that will sideline him for the entirety of the 2026 Major League Baseball season. The news, initially broken by ESPN's Jeff Passan on Tuesday, indicates that the 33-year-old player will be ineligible to participate in any regular season games, postseason play, or the upcoming World Baseball Classic. This severe penalty also carries significant financial repercussions, as Profar is expected to forfeit his entire $15 million salary for the 2026 MLB season. The reported suspension marks a critical juncture in Profar's career, impacting both his future with the Braves and his international playing commitments. Reports suggest that the Braves will now have to navigate the upcoming season without a key offensive contributor, prompting immediate questions about their roster strategy and depth.
This reported second violation follows an earlier incident last year, specifically on March 31, when Profar tested positive for human chorionic gonadotropin (HCG). HCG, a hormone typically associated with pregnancy, is known to stimulate testosterone production in males, making it a banned substance under MLB's performance-enhancing drug policy. The initial positive test resulted in an 80-game suspension for Profar and rendered him ineligible for postseason play. Coincidentally, the Atlanta Braves did not qualify for the postseason that year, marking their first absence in eight seasons. Profar's journey to the Braves included a notable 2024 season with the San Diego Padres, where he earned both an All-Star selection and a Silver Slugger Award, achievements that preceded his signing of a three-year, $42 million contract with Atlanta. The current situation casts a long shadow over his recent career resurgence and future prospects.
The financial ramifications of this reported suspension are considerable for Profar. According to reports from ESPN's Jeff Passan, he is set to forfeit the remaining $15 million on his contract for the 2026 MLB season. This sum represents the final year of the three-year, $42 million deal he inked with the Braves. Beyond the financial penalty and the loss of his MLB season, Profar's ineligibility extends to international competitions. He was slated to represent the Netherlands in the upcoming World Baseball Classic, a team that typically includes players from his native Curaçao. However, Passan's reporting confirms that this opportunity will also be lost. The league's policy regarding repeat offenders for performance-enhancing drugs was strengthened in 2014, increasing the penalty for a second violation to a full-season suspension, a rule that now directly impacts Profar's career.
The reported 162-game suspension for Jurickson Profar carries profound implications for both the player and the Atlanta Braves organization. For Profar, missing an entire season, forfeiting a substantial salary, and being barred from international play represents a significant setback, potentially jeopardizing the trajectory of his career and his standing within the sport. The incident also underscores the stringent nature of Major League Baseball's anti-doping policies, particularly the full-season ban for repeat offenders implemented in 2014, which aims to deter the use of prohibited substances. For the Braves, the sudden absence of their designated hitter for the 2026 season creates an immediate void in their lineup, necessitating strategic adjustments and potentially a search for a replacement. This situation highlights the constant challenges teams face in managing roster stability amidst player conduct issues and league regulations.
In summary, Jurickson Profar, the Atlanta Braves' designated hitter, is reportedly facing a career-altering 162-game suspension following a second positive test for performance-enhancing drugs within a year. This penalty will see him miss the entire 2026 MLB season, including any potential postseason appearances, and render him ineligible for the World Baseball Classic. Furthermore, he is expected to forfeit his $15 million salary for that year, a substantial financial blow. This development follows an earlier 80-game suspension for testing positive for HCG. The severity of the current reported punishment reflects MLB's firm stance on drug violations, particularly for repeat offenders. The Braves will now need to adapt their plans for the upcoming season, while Profar faces a challenging path forward in his professional baseball career.